MedCity News July 22, 2024
The advancement, adoption of, and access to these options – regardless of age, geography, and financial considerations – requires the support of the scientific community, drug developers, funders, regulatory agencies, insurers, and lawmakers to make the concept of a hormone-free future a reality.
Women’s reproductive rights in the U.S. are narrowing. Meanwhile, 46% of all pregnancies in the U.S. are unintended, pointing to the stark evidence of the enduring need for access to effective, acceptable contraceptive options. Pregnancy termination is rarely a desirable option. However, its growing scarcity demands that we continue to explore new approaches to a problem that’s as old as humanity. In a country of abundance, we’re in a unique position to rethink and innovate contraceptives.
...Today's Sponsors
Today's Sponsor